XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration Agreements, License Agreement and Revenues - Eluminex Agreement - Additional Information 2 (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2021
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]            
Total revenue   $ 15,735   $ 155,973 $ 106,367 $ 218,766
Eluminex [Member]            
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]            
Aggregate consideration received for milestone and upfront payments $ 8,000          
Future manufacturing clinical regulatory and commercial milestone payments 64,000          
Commercial milestone $ 36,000          
Eluminex [Member] | Cornea Products [Member] | ASC 606 [Member]            
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]            
Percentage of product manufacturing costs until manufacturing technology fully transferred     10.00%